|
Since November 1996, Dr. Engelsen has been a partner of Teknoinvest Management AS, a venture capital firm based in Norway. From 1989 until September 1996, Dr. Engelsen held various management positions within Hafslund Nycomed AS, a pharmaceutical company based in Europe, and affiliated companies. He was responsible for therapeutic research and development, most recently serving as Senior Vice President, Research and Development of Nycomed Pharma AS from January 1994 until September 1996. Dr. Engelsen is a director of several privately-held companies. Dr. Engelsen received a M.Sc. degree in nuclear chemistry and his M.D. degree from the University of Oslo, and is a Certified European Financial Analyst. Dr. Engelsen has served as a director of Insmed Pharmaceuticals since 1998.
| 